Applying the System Asset Pricing Model
Decision Accounting
Applying the System Asset Pricing Model to Private Equity in Healthcare: Measuring the System Welfare Cost of Financial Extraction from Essential Medical Infrastructure
core-claim
Core Claim
Private equity in healthcare is a net welfare destroyer, not a transfer
Each dollar of PE private payoff imposes 5.24 in system welfare cost on patients, workers, communities, and taxpayers. The system-adjusted payoff is deeply negative: ΠSA = −88 billion/year.
- βW = 0.65 [90% CI: 4.0–6.8] — ratio of system welfare cost to private payoff
- Π = $31 billion/year in GP fees, carried interest, and dividend recaps
- ΠC = $162 billion/year in welfare destruction across six channels
- No impossibility theorem applies; welfare destruction is institutionally reversible
measurement-gap
Measurement Gap
IRR records the 800 million Cerberus extracted; it does not record the 3.4 billion in liabilities left behind
Standard financial metrics (IRR, MOIC, alpha) exclude welfare costs that fall on patients, workers, communities, and taxpayers. The gap is one of measurement: the metrics that govern PE investment decisions omit system consequences.
- Cerberus extracted 800 million from Steward Health Care; Steward left 3.4 billion in liabilities, closed two hospitals
- 13% increase in ER mortality after PE acquisition (Singh et al. 2025)
- 25.4% increase in hospital-acquired conditions (Kannan & Song 2023)
- 20,150 excess nursing home deaths over 12 years (Gupta et al.)
pigou-coase-fail
Why Pigou and Coase Fail
Healthcare PE extraction breaks both textbook externality remedies
Pigouvian taxes require observable marginal costs, a single margin, and behavioral response — all three fail. Coasean bargaining requires clear property rights, low transaction costs, small numbers, and symmetric information — all four fail.
- Welfare costs manifest with lags of 1–14 years (Steward: acquisition 2010, bankruptcy 2024)
- PE extraction operates across multiple simultaneous margins: staffing cuts, sale-leasebacks, roll-ups
- Patients cannot be identified ex ante; transaction costs of organizing 330 million consumers are infinite
- 99.9% of physician practice acquisitions fell below HSR reporting threshold (Cooper et al. 2025)
sapm-framework
SAPM Framework
SAPM maps CAPM objects to welfare analogues, adding patient harm
The System Asset Pricing Model prices a private activity's system-adjusted payoff relative to a welfare baseline. It produces a system beta (βW), system-adjusted payoff (ΠSA), Pareto System Frontier, and break-even correction threshold (μ*).
- CAPM: asset return vs. market portfolio → SAPM: private payoff vs. system welfare
- βW = ΠC / Π = 0.65 (each dollar of industry revenue generates $5.24 in welfare cost)
- ΠSA = Π − ΠC = −88 billion/year [90% CI: −179B to −$93B]
- μ* = 0.86: regulatory reform must eliminate ≥81% of externalized costs to reach Pareto non-destruction
six-channels
Six Welfare Channels
Six channels of welfare destruction, each calibrated from peer-reviewed data
The channels are excess mortality, hospital-acquired morbidity, cost inflation and consumer surplus destruction, access loss from closures and consolidation, workforce degradation, and governance/institutional failure. Each contributes a channel-specific beta.
- Mortality: 13% ER mortality increase (Singh), 20,150 nursing home deaths (Gupta)
- Morbidity: 25.4% increase in HACs, including 37.7% increase in CLABSIs (Kannan & Song)
- Cost inflation: 3.3% price increase for labor/delivery at hospitals, 15.1% for physicians (Cooper et al.)
- Access loss: REIT-acquired hospitals 5x more likely to close or file bankruptcy (Bruch et al.)
- Workforce: 18% reduction in ER salary expenditures (Singh)
- Governance: $75 million dark-money campaign against No Surprises Act; exploitation of sub-HSR thresholds
aggregate-beta
Aggregate Beta
βW = 0.65: each dollar of PE payoff costs society $5.24
The aggregate system beta is calibrated from 100,000 Monte Carlo draws across channel weights and dose-response parameters. The 90% confidence interval [4.0–6.8] does not include 1.0, the welfare break-even threshold.
- P(βW < 1) = 0.0000% — zero probability that PE healthcare is welfare-neutral or positive
- ΠC = 162 billion/year in welfare destruction vs. Π = 31 billion/year in private returns
- Six channels weighted by scale factor λi and channel-specific delta Δi
- tier: channel-by-channel calibration from peer-reviewed studies (JAMA, Annals, BMJ, Health Affairs)
psf-concavity
Pareto System Frontier
The next dollar extracted is worse than the last — PSF is concave with κ = 1.4
Marginal welfare cost of additional PE extraction exceeds average cost because remaining targets are increasingly fragile (rural hospitals, safety-net facilities). This has direct implications for regulatory sequencing.
- Concavity parameter κ = 1.4: marginal cost > average cost
- Additional acquisitions target increasingly fragile institutions
- 93% of most distressed healthcare companies (Moody's B3 negative or below) are PE-owned
- $36 billion in provider debt maturing in 2025; refinancing cliff through 2028
classification
Classification
PE-in-healthcare is a Type II institutional failure — positive private returns, deeply negative system returns
In the cross-domain SAPM comparison, PE-in-healthcare (βW = 0.65) falls in Class III system failure, among severe but institutionally correctable failures. Contrast with PFAS (βW = 35.2), where physical persistence creates irreversibility.
- Type II: private returns positive, social returns deeply negative, gap widening
- No physical impossibility theorem applies — welfare destruction is institutionally constructed
- Correction is possible through staffing floors, leaseback prohibitions, antitrust enforcement, liability passthrough
- The binding margin is timing: 2026–2028 debt maturity wall threatens closures before reform propagates
break-even
Break-even Correction
μ* = 0.86: regulatory reform must eliminate 81% of externalized costs
Existing reforms in Massachusetts, Oregon, and at the federal level close approximately 40–55% of the requirement. The remaining gap requires national legislation.
- Massachusetts H.5159: banned REIT hospital leasebacks, extended False Claims Act liability to upstream investors
- Oregon SB 951: state veto power over PE healthcare acquisitions, strict limits on MSO control
- CMS staffing mandate: minimum 3.48 HPRD for nursing homes
- FTC v. USAP: first federal antitrust action targeting PE roll-up strategy
- Combined effect: ~40–55% of required correction — significant but insufficient
debt-wall
Debt Maturity Wall
$36 billion in provider debt matures in 2025; the next hospital closure wave is coming
PE-backed healthcare providers face a refinancing cliff through 2028. Moody's data shows 93% of the most distressed healthcare companies are PE-owned, and PE-backed companies default at twice the non-PE rate.
- 36 billion in provider debt maturing in 2025; 25 billion in 2024
- PE-backed companies default at twice the rate of non-PE-backed
- Steward Health Care: $9 billion in liabilities, multiple hospital closures
- The debt maturity wall is the next hospital closure wave — correction must outpace extraction
objections
Objections Addressed
Twelve objections answered: PE does not bring needed capital; mortality findings are robust; VSL is standard
The paper addresses objections including that PE brings needed capital (it does not — net welfare destruction), that mortality findings are confounded (difference-in-differences designs control for confounding), and that VSL overstates costs (U.S. DOT standard $11.6 million).
- PE net-of-fee returns approximately match S&P 500 (Phalippou 2020) — no alpha generated
- Mortality findings replicated across multiple studies with different designs and populations
- VSL of 11.6 million is conservative; EPA uses 12.9 million
- Regulatory correction will not reduce healthcare investment — it will redirect it to value-creating activities
what-changes
What Changes
The conclusion changes if: βW < 1, or institutional reform eliminates ≥81% of externalized costs
The paper identifies what would change the conclusion: if the system beta were below 1 (zero probability in Monte Carlo), if welfare costs were offset by unmeasured benefits, or if regulatory reform reaches μ* ≥ 0.86. None of these conditions currently hold.
- P(βW < 1) = 0.0000% — no chance of welfare neutrality
- No evidence of offsetting benefits: PE acquisitions reduce quality and increase prices
- Current reforms close ~40–55% of required correction — gap remains
- The question is not whether correction is possible but whether political economy permits it before the debt wall
implications
Implications
PE healthcare extraction is institutionally reversible — the binding margin is timing
No physical impossibility theorem prevents correction. The welfare destruction is institutionally constructed (LBOs, sale-leasebacks, MSO structures, sub-HSR roll-ups) and therefore institutionally reversible. The 2026–2028 debt maturity wall threatens to force the worst outcomes before institutional reform can propagate.
- Correction paths exist: staffing floors, leaseback prohibitions, antitrust enforcement, liability passthrough
- Massachusetts and Oregon have enacted reforms; 79 bills across 25 states in 2025/2026
- Federal proposals: PATIENT Act, Health Over Wealth Act
- The question is whether political economy permits correction before the debt maturity wall forces hospital closures